Puerto Rico: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Puerto Rico

The Puerto Rican medicaments containing insulin market amounted to less than $X in 2021, leveling off at the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, consumption showed a relatively flat trend pattern.

Medicaments Containing Insulin Exports

Exports from Puerto Rico

Medicaments containing insulin exports from Puerto Rico stood at less than X kg in 2021, approximately reflecting 2020. In general, exports saw a relatively flat trend pattern.

In value terms, medicaments containing insulin exports totaled less than $X in 2021. Over the period under review, exports showed a relatively flat trend pattern.

Exports by Country

The United States dominates exports structure, resulting at X tons, which was approx. 92% of total exports in 2021. It was distantly followed by , creating a 0% share of total exports. Thailand (X tons), the Netherlands (X tons), India (X tons) and Denmark (X tons) took a little share of total exports.

Exports from the United States increased at an average annual rate of +13.1% from 2012 to 2021. At the same time, Thailand (+102.4%) displayed positive paces of growth. Moreover, Thailand emerged as the fastest-growing exporter exported in the world, with a CAGR of +102.4% from 2012-2021. Germany experienced a relatively flat trend pattern. By contrast, Denmark (-24.5%), India (-35.1%) and the Netherlands (-73.3%) illustrated a downward trend over the same period. From 2012 to 2021, the share of the United States and Thailand increased by +39 and +2.7 percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United States ($X) remains the largest medicaments containing insulin supplier from Puerto Rico, comprising 84% of global exports. The second position in the ranking was held by Thailand ($X), with a 0.6% share of global exports. It was followed by Denmark, with a 0.5% share.

In the United States, medicaments containing insulin exports declined by an average annual rate of -6.6% over the period from 2012-2021. The remaining exporting countries recorded the following average annual rates of exports growth: Thailand (+48.3% per year) and Denmark (-36.9% per year).

Export Prices by Country

The export price in Puerto Rico stood at less than $X per ton in 2021, remaining relatively unchanged against the previous year. Over the period under review, the export price showed a relatively flat trend pattern.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Netherlands (+114.8%), while the other leaders experienced mixed trends in the export price figures.

Medicaments Containing Insulin Imports

Imports into Puerto Rico

In 2021, approx. less than X kg of medicaments containing insulin but not antibiotics were imported into Puerto Rico; remaining stable against 2020. In general, imports recorded a relatively flat trend pattern.

In value terms, medicaments containing insulin imports totaled less than $X in 2021. Over the period under review, imports showed a relatively flat trend pattern.

Imports by Country

Denmark (X tons) represented the major importers of medicaments containing insulin but not antibiotics in 2021, finishing at near 67% and 0% of total imports, respectively. It was distantly followed by Brazil (X tons), Malaysia (X tons) and Russia (X tons), together achieving a 12% share of total imports. Nigeria (X tons), Kuwait (X tons), Ethiopia (X tons), Japan (X tons), China (X tons) and Tunisia (X tons) followed a long way behind the leaders.

From 2012 to 2021, average annual rates of growth with regard to medicaments containing insulin but not antibiotics imports into Denmark and Italy stood at +27.5% and -41.4%, respectively. At the same time, Brazil (+42.6%), Japan (+32.4%), Ethiopia (+17.3%), Kuwait (+8.8%) and Malaysia (+2.0%) displayed positive paces of growth. Moreover, Brazil emerged as the fastest-growing importer imported in the world, with a CAGR of +42.6% from 2012-2021. By contrast, Nigeria (-2.5%), Tunisia (-22.6%), Russia (-41.8%) and China (-47.3%) illustrated a downward trend over the same period. Denmark (+67 p.p.), Brazil (+6.7 p.p.), Malaysia (+3.8 p.p.), Kuwait (+2.5 p.p.), Nigeria (+2 p.p.), Ethiopia (+2 p.p.) and Japan (+1.6 p.p.) significantly strengthened its position in terms of the global imports, while China, Russia and Italy saw its share reduced by -7.6%, -11.7% and -70.5% from 2012 to 2021, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics into Puerto Rico, comprising 66% of global imports. The second position in the ranking was taken by Brazil ($X), with a 6.3% share of global imports. It was followed by Russia, with a 5.7% share.

In Denmark, medicaments containing insulin imports increased at an average annual rate of +20.7% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Brazil (+37.4% per year) and Russia (-27.6% per year).

Import Prices by Country

In 2021, the import price in Puerto Rico amounted to less than $X per ton, approximately equating the previous year. In general, the import price continues to indicate a relatively flat trend pattern.

There were significant differences in the average prices amongst the major importing countries. In 2021, amid the top importers, the country with the highest price was Russia ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Russia (+24.4%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :